51 results
Page 3 of 3
8-K
EX-1.2
et8ynesp
21 Feb 19
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
4:53pm
S-3
EX-1.2
bg8wifzb
1 Jun 18
Shelf registration
5:14pm
10-K
i60cvgqas 9k
29 Mar 18
Annual report
12:00am
10-Q
caa egrddo2n33ahuh
13 Jun 17
Quarterly report
12:00am